TCT 420: Predictive Value of Coronary CT-derived Plaque and FFR Analysis in Patients with Peripheral Artery Disease and No Known Coronary Disease

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Boston Scientific Corporation; Heartflow</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Abbott; Biotronik; Boston Scientific Corporation; Biosensors</li></ul>